114 related articles for article (PubMed ID: 16464484)
1. Hypoxia- and radiation-inducible, breast cell-specific targeting of retroviral vectors.
Lipnik K; Greco O; Scott S; Knapp E; Mayrhofer E; Rosenfellner D; Günzburg WH; Salmons B; Hohenadl C
Virology; 2006 May; 349(1):121-33. PubMed ID: 16464484
[TBL] [Abstract][Full Text] [Related]
2. The murine whey acidic protein promoter directs expression to human mammary tumors after retroviral transduction.
Oztürk-Winder F; Renner M; Klein D; Müller M; Salmons B; Günzburg WH
Cancer Gene Ther; 2002 May; 9(5):421-31. PubMed ID: 11961665
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional targeting of acute hypoxia in the tumour stroma is a novel and viable strategy for cancer gene therapy.
Ingram N; Porter CD
Gene Ther; 2005 Jul; 12(13):1058-69. PubMed ID: 15800661
[TBL] [Abstract][Full Text] [Related]
4. WPRE-mediated enhancement of gene expression is promoter and cell line specific.
Klein R; Ruttkowski B; Knapp E; Salmons B; Günzburg WH; Hohenadl C
Gene; 2006 May; 372():153-61. PubMed ID: 16488559
[TBL] [Abstract][Full Text] [Related]
5. [Oncostatin M gene therapy in mice bearing lung adenocarcinoma xenograft using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):240-3. PubMed ID: 15144614
[TBL] [Abstract][Full Text] [Related]
6. Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches.
Brandtner EM; Kodajova P; Hlavaty J; Jandl G; Tabotta W; Salmons B; Günzburg WH; Hohenadl C
J Gene Med; 2008 Feb; 10(2):113-22. PubMed ID: 18076132
[TBL] [Abstract][Full Text] [Related]
7. Employment of the mdr1 promoter for the chemotherapy-inducible expression of therapeutic genes in cancer gene therapy.
Walther W; Wendt J; Stein U
Gene Ther; 1997 Jun; 4(6):544-52. PubMed ID: 9231070
[TBL] [Abstract][Full Text] [Related]
8. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
Lillehammer T; Tveito S; Engesaeter BO; Fodstad O; Maelandsmo GM; Engebraaten O
Cancer Gene Ther; 2005 Nov; 12(11):864-72. PubMed ID: 15891771
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro expression of human serum albumin genomic sequences in mammary epithelial cells with beta-lactoglobulin and whey acidic protein promoters.
Barash I; Faerman A; Richenstein M; Kari R; Damary GM; Shani M; Bissell MJ
Mol Reprod Dev; 1999 Mar; 52(3):241-52. PubMed ID: 10206655
[TBL] [Abstract][Full Text] [Related]
10. Retroviral vector targeting for gene therapy.
Günzburg WH; Fleuchaus A; Saller R; Salmons B
Cytokines Mol Ther; 1996 Sep; 2(3):177-84. PubMed ID: 9384702
[TBL] [Abstract][Full Text] [Related]
11. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.
Laurie KL; Blundell MP; Baxendale HE; Howe SJ; Sinclair J; Qasim W; Brunsberg U; Thrasher AJ; Holmdahl R; Gustafsson K
Gene Ther; 2007 Dec; 14(23):1623-31. PubMed ID: 17851547
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
13. A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons.
Huang D; Desbois A; Hou ST
Gene Ther; 2005 Sep; 12(18):1369-76. PubMed ID: 15843806
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
15. Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy.
Scott SD; Joiner MC; Marples B
Gene Ther; 2002 Oct; 9(20):1396-402. PubMed ID: 12365005
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
17. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
Petrigliano FA; Virk MS; Liu N; Sugiyama O; Yu D; Lieberman JR
Prostate; 2009 Sep; 69(13):1422-34. PubMed ID: 19489029
[TBL] [Abstract][Full Text] [Related]
18. [*OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells].
Yao DS; Li L; Garson K; Vanderhyden BC
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):333-8. PubMed ID: 16762191
[TBL] [Abstract][Full Text] [Related]
19. The cytotoxic activity of the bacteriophage lambda-holin protein reduces tumour growth rates in mammary cancer cell xenograft models.
Agu CA; Klein R; Schwab S; König-Schuster M; Kodajova P; Ausserlechner M; Binishofer B; Bläsi U; Salmons B; Günzburg WH; Hohenadl C
J Gene Med; 2006 Feb; 8(2):229-41. PubMed ID: 16170834
[TBL] [Abstract][Full Text] [Related]
20. Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma.
Barzon L; Gnatta E; Castagliuolo I; Trevisan M; Moretti F; Pontecorvi A; Boscaro M; Palù G
Cancer Gene Ther; 2005 Apr; 12(4):381-8. PubMed ID: 15650765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
